Published in Blood on September 25, 2008
Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease. Nat Med (2010) 4.76
A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses. Immunity (2009) 2.59
Trithorax group proteins: switching genes on and keeping them active. Nat Rev Mol Cell Biol (2011) 2.56
Histone H3 lysine 4 (H3K4) methylation in development and differentiation. Dev Biol (2009) 2.24
MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia. Cancer Cell (2014) 1.98
Loss-of-function Additional sex combs like 1 mutations disrupt hematopoiesis but do not cause severe myelodysplasia or leukemia. Blood (2009) 1.90
MLL5, a trithorax homolog, indirectly regulates H3K4 methylation, represses cyclin A2 expression, and promotes myogenic differentiation. Proc Natl Acad Sci U S A (2009) 1.54
Molecular basis for chromatin binding and regulation of MLL5. Proc Natl Acad Sci U S A (2013) 1.15
Caenorhabditis elegans chromatin-associated proteins SET-2 and ASH-2 are differentially required for histone H3 Lys 4 methylation in embryos and adult germ cells. Proc Natl Acad Sci U S A (2011) 1.08
Histone H3 lysine 4 methyltransferases and demethylases in self-renewal and differentiation of stem cells. Cell Biosci (2013) 1.07
Mixed lineage leukemia 5 (MLL5) protein regulates cell cycle progression and E2F1-responsive gene expression via association with host cell factor-1 (HCF-1). J Biol Chem (2013) 1.04
UpSET recruits HDAC complexes and restricts chromatin accessibility and acetylation at promoter regions. Cell (2012) 0.96
Use of chromosome engineering to model a segmental deletion of chromosome band 7q22 found in myeloid malignancies. Blood (2010) 0.90
Mll5 is required for normal spermatogenesis. PLoS One (2011) 0.89
Solution NMR structure and histone binding of the PHD domain of human MLL5. PLoS One (2013) 0.88
Phosphorylation of mixed lineage leukemia 5 by CDC2 affects its cellular distribution and is required for mitotic entry. J Biol Chem (2010) 0.86
Molecular and Epigenetic Mechanisms of MLL in Human Leukemogenesis. Cancers (Basel) (2012) 0.83
Impact of MLL5 expression on decitabine efficacy and DNA methylation in acute myeloid leukemia. Haematologica (2014) 0.83
MLL5 maintains genomic integrity by regulating the stability of the chromosomal passenger complex through a functional interaction with Borealin. J Cell Sci (2012) 0.83
Mixed Lineage Leukemia 5 (MLL5) Protein Stability Is Cooperatively Regulated by O-GlcNac Transferase (OGT) and Ubiquitin Specific Protease 7 (USP7). PLoS One (2015) 0.82
MLL5 governs hematopoiesis: a step closer. Blood (2009) 0.81
Association of the histone-lysine N-methyltransferase MLL5 gene with coronary artery disease in Chinese Han people. Meta Gene (2014) 0.76
MLL5 expression as a biomarker for DNA hypermethylation and sensitivity to epigenetic therapy. Haematologica (2014) 0.76
Reduced levels of Hspa9 attenuate Stat5 activation in mouse B cells. Exp Hematol (2014) 0.76
UpSET-ting the balance: modulating open chromatin features in metazoan genomes. Fly (Austin) (2013) 0.76
Multiplex meta-analysis of RNA expression to identify genes with variants associated with immune dysfunction. J Am Med Inform Assoc (2012) 0.76
The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity. PLoS One (2016) 0.75
KMT2E-ASNS: a novel relapse-specific fusion gene in early T-cell precursor acute lymphoblastic leukemia. Blood (2017) 0.75
Newly emerged isolated Del(7q) in patients with prior cytotoxic therapies may not always be associated with therapy-related myeloid neoplasms. Mod Pathol (2016) 0.75
upSET, the Drosophila Homologue of SET3, Is Required for Viability and the Proper Balance of Active and Repressive Chromatin Marks. G3 (Bethesda) (2017) 0.75
MLL5 maintains spindle bipolarity by preventing aberrant cytosolic aggregation of PLK1. J Cell Biol (2016) 0.75
Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19
Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol (2000) 128.08
A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics (2003) 82.89
A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A (2004) 44.81
SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell (2005) 24.00
Inducible gene targeting in mice. Science (1995) 21.22
A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res (1961) 18.57
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes Dev (2001) 15.97
Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells. Nature (2003) 14.35
FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell (2007) 12.33
Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature (2006) 11.86
Maintenance of the hematopoietic stem cell pool by CXCL12-CXCR4 chemokine signaling in bone marrow stromal cell niches. Immunity (2006) 11.28
Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature (2001) 10.56
MLL targets SET domain methyltransferase activity to Hox gene promoters. Mol Cell (2002) 8.17
Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu Rev Immunol (2002) 7.78
PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention. Nature (2006) 7.35
The polycomb-group gene Ezh2 is required for early mouse development. Mol Cell Biol (2001) 7.20
A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Res (2003) 6.76
ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol Cell (2002) 6.72
Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nat Genet (1999) 6.61
Altered Hox expression and segmental identity in Mll-mutant mice. Nature (1995) 6.60
Foxo3a is essential for maintenance of the hematopoietic stem cell pool. Cell Stem Cell (2007) 5.94
Obligate role of anti-apoptotic MCL-1 in the survival of hematopoietic stem cells. Science (2005) 4.75
Genome-scale RNAi profiling of cell division in human tissue culture cells. Nat Cell Biol (2007) 3.91
The PHD finger, a nuclear protein-interaction domain. Trends Biochem Sci (2005) 3.56
Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder. Proc Natl Acad Sci U S A (2003) 3.46
Zfx controls the self-renewal of embryonic and hematopoietic stem cells. Cell (2007) 3.41
Multiple epigenetic maintenance factors implicated by the loss of Mll2 in mouse development. Development (2006) 3.28
Structural and sequence motifs of protein (histone) methylation enzymes. Annu Rev Biophys Biomol Struct (2005) 3.17
Chromosome translocations: dangerous liaisons revisited. Nat Rev Cancer (2001) 3.01
MLL: a histone methyltransferase disrupted in leukemia. Trends Mol Med (2004) 2.97
Limiting factors in murine hematopoietic stem cell assays. Cell Stem Cell (2007) 2.89
Unique and independent roles for MLL in adult hematopoietic stem cells and progenitors. Cell Stem Cell (2007) 2.82
The S. cerevisiae SET3 complex includes two histone deacetylases, Hos2 and Hst1, and is a meiotic-specific repressor of the sporulation gene program. Genes Dev (2001) 2.76
Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. Blood (2003) 2.76
Transcription factor Gfi1 regulates self-renewal and engraftment of hematopoietic stem cells. EMBO J (2004) 2.57
Tel/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survival. Genes Dev (2004) 2.56
Clearance of apoptotic cells by phagocytes. Cell Death Differ (2007) 2.53
New evidence supporting megakaryocyte-erythrocyte potential of flk2/flt3+ multipotent hematopoietic progenitors. Cell (2006) 2.34
Haploinsufficiency of EGR1, a candidate gene in the del(5q), leads to the development of myeloid disorders. Blood (2007) 2.30
Mll has a critical role in fetal and adult hematopoietic stem cell self-renewal. Cell Stem Cell (2007) 2.23
Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S. J Clin Invest (2002) 2.22
Haploinsufficiency of AML1 affects the temporal and spatial generation of hematopoietic stem cells in the mouse embryo. Immunity (2000) 2.10
Defects in yolk sac hematopoiesis in Mll-null embryos. Blood (1997) 2.06
Growth disturbance in fetal liver hematopoiesis of Mll-mutant mice. Blood (1998) 2.06
High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia. Blood (2003) 1.80
Cytogenetic and molecular delineation of a region of chromosome 7 commonly deleted in malignant myeloid diseases. Blood (1996) 1.77
MLL5, a homolog of Drosophila trithorax located within a segment of chromosome band 7q22 implicated in myeloid leukemia. Oncogene (2002) 1.62
Polycomb group gene rae28 is required for sustaining activity of hematopoietic stem cells. J Exp Med (2002) 1.62
AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML. Oncogene (2001) 1.42
Haploinsufficiency of AML1 results in a decrease in the number of LTR-HSCs while simultaneously inducing an increase in more mature progenitors. Blood (2004) 1.35
Childhood monosomy 7: epidemiology, biology, and mechanistic implications. Blood (1995) 1.33
Smad4 is critical for self-renewal of hematopoietic stem cells. J Exp Med (2007) 1.25
Accommodating haploinsufficient tumor suppressor genes in Knudson's model. Oncogene (2000) 1.19
MLL 5 protein forms intranuclear foci, and overexpression inhibits cell cycle progression. Proc Natl Acad Sci U S A (2004) 1.16
Regulation of hematopoietic stem cells by the niche. Trends Cardiovasc Med (2005) 1.06
RNA interference against mixed lineage leukemia 5 resulted in cell cycle arrest. Int J Biochem Cell Biol (2008) 1.01
A gene-trap strategy identifies quiescence-induced genes in synchronized myoblasts. J Biosci (2008) 0.98
Isolation and analysis of candidate myeloid tumor suppressor genes from a commonly deleted segment of 7q22. Genomics (2005) 0.96
AML1/Runx1 as a versatile regulator of hematopoiesis: regulation of its function and a role in adult hematopoiesis. Int J Hematol (2006) 0.93
Candidate gene isolation and comparative analysis of a commonly deleted segment of 7q22 implicated in myeloid malignancies. Genomics (2001) 0.91
Effects of 5-fluorouracil on mouse bone marrow. Br J Haematol (1979) 0.87
Role of AML1/Runx1 in the pathogenesis of hematological malignancies. Cancer Sci (2003) 0.86
Asymmetric T lymphocyte division in the initiation of adaptive immune responses. Science (2007) 7.64
Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1high germinal center-associated subpopulation. J Immunol (2007) 5.14
Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon. Nat Genet (2008) 5.07
Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses. Nat Immunol (2004) 4.41
Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlates. Cancer Cell (2008) 4.06
Mammalian target of rapamycin protein complex 2 regulates differentiation of Th1 and Th2 cell subsets via distinct signaling pathways. Immunity (2010) 4.06
Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder. Proc Natl Acad Sci U S A (2003) 3.46
Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen. Immunity (2013) 3.07
A two-step process for cytokine production revealed by IL-4 dual-reporter mice. Immunity (2005) 3.02
Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis. Blood (2003) 2.76
OX40 costimulation turns off Foxp3+ Tregs. Blood (2007) 2.52
Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder. Blood (2004) 2.42
Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR. Blood (2004) 2.38
The protein disulfide isomerase AGR2 is essential for production of intestinal mucus. Proc Natl Acad Sci U S A (2009) 2.30
Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells. J Immunol (2004) 2.28
Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia. Blood (2012) 2.17
Mutations in CBL occur frequently in juvenile myelomonocytic leukemia. Blood (2009) 2.15
Functional analysis of leukemia-associated PTPN11 mutations in primary hematopoietic cells. Blood (2005) 1.96
Resynchronization therapy in pediatric and congenital heart disease patients: an international multicenter study. J Am Coll Cardiol (2005) 1.90
Activation of an oncogenic microRNA cistron by provirus integration. Proc Natl Acad Sci U S A (2006) 1.83
GTPase activating proteins: critical regulators of intracellular signaling. Biochim Biophys Acta (2002) 1.74
CCR7 directs the migration of thymocytes into the thymic medulla. J Immunol (2004) 1.72
Selective expression of the Cre recombinase in late-stage thymocytes using the distal promoter of the Lck gene. J Immunol (2005) 1.68
Targeting oncogenic Ras signaling in hematologic malignancies. Blood (2012) 1.67
Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy. J Am Coll Cardiol (2013) 1.65
Phosphoinositide 3-kinase activity in T cells regulates the magnitude of the germinal center reaction. J Immunol (2010) 1.63
MLL5, a homolog of Drosophila trithorax located within a segment of chromosome band 7q22 implicated in myeloid leukemia. Oncogene (2002) 1.62
Focus on myeloproliferative diseases and myelodysplastic syndromes. Cancer Cell (2004) 1.52
Long-term survival after cardiac arrest in hypertrophic cardiomyopathy. Heart Rhythm (2009) 1.50
Characterization of anatomic ventricular tachycardia isthmus pathology after surgical repair of tetralogy of Fallot. Circ Arrhythm Electrophysiol (2013) 1.43
A genetically selective inhibitor demonstrates a function for the kinase Zap70 in regulatory T cells independent of its catalytic activity. Nat Immunol (2010) 1.42
Essential role for Ptpn11 in survival of hematopoietic stem and progenitor cells. Blood (2011) 1.36
Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01. Blood (2006) 1.28
Impact of the TCR signal on regulatory T cell homeostasis, function, and trafficking. PLoS One (2009) 1.23
Generalized immune activation as a direct result of activated CD4+ T cell killing. J Biol (2009) 1.22
Thymic OX40 expression discriminates cells undergoing strong responses to selection ligands. J Immunol (2009) 1.18
Gain of MYC underlies recurrent trisomy of the MYC chromosome in acute promyelocytic leukemia. J Exp Med (2010) 1.15
Immune complex-dependent remodeling of the airway vasculature in response to a chronic bacterial infection. J Immunol (2005) 1.14
Hyperactivation of protein kinase B and ERK have discrete effects on survival, proliferation, and cytokine expression in Nf1-deficient myeloid cells. Cancer Cell (2002) 1.14
Detection of circulating tumour DNA in patients with aggressive B-cell non-Hodgkin lymphoma. Br J Haematol (2013) 1.12
A retroviral mutagenesis screen reveals strong cooperation between Bcl11a overexpression and loss of the Nf1 tumor suppressor gene. Blood (2008) 1.12
SHP-2 and myeloid malignancies. Curr Opin Hematol (2004) 1.08
Acute leukemia: a pediatric perspective. Cancer Cell (2002) 1.06
Harnessing preclinical mouse models to inform human clinical cancer trials. J Clin Invest (2006) 1.06
Interstitial uniparental isodisomy at clustered breakpoint intervals is a frequent mechanism of NF1 inactivation in myeloid malignancies. Blood (2006) 1.05
Therapy-induced malignant neoplasms in Nf1 mutant mice. Cancer Cell (2005) 1.04
Abnormal hematopoiesis in Gab2 mutant mice. Blood (2007) 1.04
Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients. Blood (2003) 1.03
Germline mutations in components of the Ras signaling pathway in Noonan syndrome and related disorders. Cell Cycle (2006) 1.01
Genomic structure of the PIK3CG gene on chromosome band 7q22 and evaluation as a candidate myeloid tumor suppressor. Blood (2002) 1.00
CD134 plays a crucial role in the pathogenesis of EAE and is upregulated in the CNS of patients with multiple sclerosis. J Neuroimmunol (2003) 0.98
Isolation and analysis of candidate myeloid tumor suppressor genes from a commonly deleted segment of 7q22. Genomics (2005) 0.96
Defective K-Ras oncoproteins overcome impaired effector activation to initiate leukemia in vivo. Blood (2013) 0.95
Transgenic expression of RasGRP1 induces the maturation of double-negative thymocytes and enhances the production of CD8 single-positive thymocytes. J Immunol (2003) 0.93
Accuracy and upgrade rates of percutaneous breast biopsy: the surgeon's role. Am Surg (2010) 0.93
RAS, FLT3, and TP53 mutations in therapy-related myeloid malignancies with abnormalities of chromosomes 5 and 7. Genes Chromosomes Cancer (2004) 0.92
Use of chromosome engineering to model a segmental deletion of chromosome band 7q22 found in myeloid malignancies. Blood (2010) 0.90
CCR7 expression in developing thymocytes is linked to the CD4 versus CD8 lineage decision. J Immunol (2007) 0.90
Transpulmonary atrial pacing: an approach to transvenous pacemaker implantation after extracardiac conduit Fontan surgery. J Cardiovasc Electrophysiol (2014) 0.88
Hematologic effects of inactivating the Ras processing enzyme Rce1. Blood (2002) 0.88
Generation and characterization of ecto-ADP-ribosyltransferase ART2.1/ART2.2-deficient mice. Mol Cell Biol (2002) 0.88
Ras processing as a therapeutic target in hematologic malignancies. Curr Opin Hematol (2002) 0.87
The corrected QT interval before and after heart transplantation. Am J Cardiol (2009) 0.86
Cancer: hay in a haystack. Nature (2008) 0.84
Factors associated with fluoroscopy exposure during pediatric catheter ablation utilizing electroanatomical mapping. J Interv Card Electrophysiol (2012) 0.83
Mutations in GATA2 are rare in juvenile myelomonocytic leukemia. Blood (2014) 0.82
Are percutaneous biopsy rates a reasonable quality measure in breast cancer management? Ann Surg Oncol (2010) 0.82
Electrosurgical energy in combination with a transseptal needle: a novel method for the creation of an atrial communication in hypoplastic left heart syndrome with intact atrial septum. Catheter Cardiovasc Interv (2009) 0.80
Impact of manufacturer advisories and FDA recalls of implantable cardioverter defibrillator generators in pediatric and congenital heart disease patients. J Cardiovasc Electrophysiol (2008) 0.79
When is a lymph node dissection a lymph node dissection? The number of lymph nodes resected in sentinel and axillary lymph node dissections. Ann Surg Oncol (2012) 0.78
Reporter alleles that inform on differences in Cre recombinase expression. J Immunol (2010) 0.77
Electrophysiological characterization of cardiac veins in humans. J Interv Card Electrophysiol (2004) 0.77
Beyond coronary sinus angiography: the value of coronary arteriography and identification of the pericardiophrenic vein during left ventricular lead placement. Pacing Clin Electrophysiol (2005) 0.77
Modulation of the murine CD8 gene complex following the targeted integration of human CD2-locus control region sequences. J Immunol (2011) 0.76
A new spin on an unusual tail. Nat Immunol (2002) 0.75
Incessant tachycardia following catheter ablation of an accessory pathway: what is the mechanism? Heart Rhythm (2005) 0.75
Acute myeloid leukemia associated with t(8;21) or trisomy 8 in children with neurofibromatosis, type 1. J Pediatr Hematol Oncol (2003) 0.75
A pediatric case report on arrhythmogenic right ventricular dysplasia. Congenit Heart Dis (2008) 0.75
Laparoendoscopic excision of sternal subcutaneous dermoids in children. Surg Endosc (2012) 0.75
Enhancing the Remineralization Potential of Child Formula Dentifrices: An Study. J Clin Pediatr Dent (2019) 0.75
Complications After Total Skin-Sparing Mastectomy and Expander-Implant Reconstruction: Effects of Radiation Therapy on the Stages of Reconstruction. Ann Plast Surg (2017) 0.75
Community end-of-life care for older non-cancer patients: a pilot study. Ann Acad Med Singapore (2014) 0.75
Reentry around the heart. Heart Rhythm (2006) 0.75